Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-064136)

Filing Details

Accession Number:: 0001209191-18-064136
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-26 20:01:40
Reporting Period:: 2018-12-21

Accepted Time:: 2018-12-26 20:01:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513818	Aravive Inc.	ARAV	Pharmaceutical Preparations (2834)	264106690

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1587788	Jay Shepard	C/O Aravive, Inc. Lyondellbassell Tower, 1221 Mckinney St. Houston TX 77010	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-12-21	3,484	$3.22	84,113	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs, previously reported in Table I following the date of grant.